Completed
PHASE4
INTERVENTIONAL
NCT01897324
IVF/ICSI Protocols in Poor Responders With Growth Hormone
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
in this study, we are trying to monitor the effect of the addition of growth hormone on the different down regulation protocols ( long, short, antagonist and microflare). The outcome will be primarily assessed by the clinical pregnancy rates.
Detailed Description
Poor responders undergoing IVF/ICSI cycles have emerged as a major problem. the need to find a proper stimulation protocol is a must. in this study we are trying to detect the best stimulation protocol ,in addition to growth hormone ,that can give the highest pregnancy rates in these patients.
Interventions
Name:
Growth hormone (Norditropin, Novo nordisk)
Type:
DRUG
Description:
Primary Outcomes
Measure:
Numbers of oocytes retrieved and number of fertilized oocytes
TimeFrame:
2 years
Description:
Number of oocytes retrieved on the day of vaginal egg collection guided by trans vaginal ultrasound scan , 35 hours after hCG administration.
Trial Information
NCT ID
NCT01897324
Status
Completed
Study Type
INTERVENTIONAL
Phases
PHASE4
Sponsor
Woman's Health University Hospital, Egypt
Last Updated
December 15, 2025